Latest Breaking News On - Crinetics pharmaceuticals price performance - Page 2 : comparemela.com

Oppenheimer Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48 00

Oppenheimer Raises Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandDana pizzutiStephenf betzAnalyst recommendations for crinetics pharmaceuticalsWellington management groupInstitutional trading of crinetics pharmaceuticalsPricet rowe associates incCrinetics pharmaceuticals price performanceJennison associatesJefferies financial groupMorgan stanleyBlackrock incVanguard group incNews ratings for crinetics pharmaceuticals dailyCantor fitzgerald

MBB Public Markets I LLC Has $259,000 Stock Position in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)

MBB Public Markets I LLC Has $259,000 Stock Position in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dana pizzutiStephenf betzChina universal asset management coNews ratings for crinetics pharmaceuticals dailyJpmorgan chase coMorgan stanleyOsaic holdings incCrinetics pharmaceuticalsCrinetics pharmaceuticals incRoyal bankTower research capitalCantor fitzgeraldQuarter for crinetics pharmaceuticalsCrinetics pharmaceuticals price performanceJefferies financial groupCrinetics pharmaceuticals profile

Profund Advisors LLC Increases Stake in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)

Profund Advisors LLC Increases Stake in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stephenf betzMarc wilsonBlackrock incJennison associatesExchange commissionJpmorgan chase coMorgan stanleySecurities exchange commissionCrinetics pharmaceuticals profileCrinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticals incJefferies financial groupCrinetics pharmaceuticals price performanceCantor fitzgeraldProfund advisors

Crinetics Pharmaceuticals (NASDAQ:CRNX) Earns Overweight Rating from Cantor Fitzgerald

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a note issued to investors on Friday, Benzinga reports. They presently have a $50.00 target price on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 38.73% from the stock’s previous close. CRNX […]

Dana pizzutiStephenf betzCantor fitzgeraldMorgan stanleyJefferies financial groupCrinetics pharmaceuticals price performanceMirae asset global investments coJennison associatesCrinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticals company profileWealth partnersJpmorgan chase coAnalyst recommendations for crinetics pharmaceuticalsCrinetics pharmaceuticals incGet free report

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives $44 90 Average PT from Brokerages

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average twelve-month target […]

Richard scott struthersStephenf betzHighmark wealth managementCrinetics pharmaceuticals price performanceRoyal bankCrinetics pharmaceuticals incJefferies financial groupInstitutional trading of crinetics pharmaceuticalsChina universal asset management coOsaic holdings incNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticalsAnalyst recommendations for crinetics pharmaceuticalsCantor fitzgeraldCrinetics pharmaceuticals company profileJpmorgan chase co